Efficacy of 0.9% Spinosad Topical Suspension in The Eradication of Scabies
Islami Bank Medical College Journal · 31.01.2026 · 21 (1) · 58-61
DOI: 10.70945/ibmcj.v021i01.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Islami Bank Medical College Journal, online erschienen am 31.01.2026. Verfasst von Iqbal Ahmed und 2 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Scabies is a highly contagious parasitic skin infestation caused by Sarcoptes scabiei var. hominis, leading to intense pruritus, characteristic lesions, and secondary complications in chronic cases. Conventional treatments, including permethrin and oral ivermectin, may face challenges such as resistance, poor compliance, and limited efficacy in certain populations. Spinosad, a naturally derived compound, has shown promise as a safe and effective topical treatment for ectoparasitic infestations, with potential advantages over traditional therapies.
Objective
To evaluate the efficacy and safety of 0.9% spinosad topical suspension in the eradication of scabies.
Methods
This single-center, randomized, double-blind, vehicle-controlled trial enrolled 50 subjects (25 per group) from dermatology outpatient departments in Al Haramain Hospital Pvt. Ltd., Sylhet, Bangladesh. Participants with clinically and microscopically confirmed scabies were randomly assigned to receive either a single application of 0.9% spinosad or vehicle. The study duration was 28 days, with follow-up visits on Days 7, 14, and 28. Primary efficacy was assessed as the proportion of subjects achieving complete cure on Day 28. Secondary endpoints included clinical cure, microscopic cure, reduction in lesion count, and occurrence of new lesions. Safety and tolerability were monitored throughout the study.
Results
Baseline characteristics were comparable between groups. By Day 28, 76.0% of subjects treated with spinosad achieved complete cure compared to 40.0% in the vehicle group. Clinical cure was observed in 80.0% versus 40.0%, and microscopic cure in 84.0% versus 52.0% for spinosad and vehicle groups, respectively. The spinosad group also showed a greater reduction in lesion count (−11.0 vs −6.0) and fewer new lesions (1.0% vs 5.0%). All differences were statistically significant (P ≤ 0.001). No serious adverse events were reported, and spinosad was well-tolerated.
Conclusion
A single application of 0.9% spinosad topical suspension is highly effective and safe for the treatment of scabies. It achieves superior clinical and microscopic cure rates, reduces lesion counts, and minimizes new lesion formation, making it a promising alternative to conventional therapies in both adults and children in Bangladesh.
Zitieren
APA
Ahmed, I., Das, S., & Suman, M. R. A. (2026). Efficacy of 0.9% Spinosad Topical Suspension in The Eradication of Scabies. Islami Bank Medical College Journal, 21(1), 58-61. https://doi.org/10.70945/ibmcj.v021i01.021
Vancouver
Ahmed I, Das S, Suman MRA. Efficacy of 0.9% Spinosad Topical Suspension in The Eradication of Scabies. Islami Bank Medical College Journal. 2026;21(1):58-61. doi:10.70945/ibmcj.v021i01.021
BibTeX
@article{Ahmed2026,
author = {Ahmed, Iqbal and Das, Shuvashis and Suman, Md Rajib Ahasan},
title = {Efficacy of 0.9% Spinosad Topical Suspension in The Eradication of Scabies},
journal = {Islami Bank Medical College Journal},
year = {2026},
volume = {21},
number = {1},
pages = {58--61},
doi = {10.70945/ibmcj.v021i01.021}
}
EUVIMED